Meixner, E., Hörner-Rieber, J., Lischalk, J. W., Eichkorn, T., Krämer, A. S., Sandrini, E., . . . König, L. (2023). Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids. Clinical and translational radiation oncology, 39, . https://doi.org/10.1016/j.ctro.2023.100600
Chicago-Zitierstil (17. Ausg.)Meixner, Eva, et al. "Management of Initial and Recurrent Radiation-induced Contrast Enhancements Following Radiotherapy for Brain Metastases: Clinical and Radiological Impact of Bevacizumab and Corticosteroids." Clinical and Translational Radiation Oncology 39 (2023). https://doi.org/10.1016/j.ctro.2023.100600.
MLA-Zitierstil (9. Ausg.)Meixner, Eva, et al. "Management of Initial and Recurrent Radiation-induced Contrast Enhancements Following Radiotherapy for Brain Metastases: Clinical and Radiological Impact of Bevacizumab and Corticosteroids." Clinical and Translational Radiation Oncology, vol. 39, 2023, https://doi.org/10.1016/j.ctro.2023.100600.